![Hiroki Narita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiroki Narita
Direttore/Membro del Consiglio presso
Cardio, Inc.
Profilo
Hiroki Narita is currently the Director at Cardio, Inc. and the Senior Managing Director at Daiwa Corporate Investment Co., Ltd. He previously held positions as an Outside Director at REGiMMUNE Corp., an Outside Director at TMRC Co. Ltd., a Director at Ribomic, Inc., an Outside Director at RaQualia Pharma, Inc., and a Deputy General Manager at Daiwa SMBC Capital Co., Ltd. Mr. Narita completed his undergraduate degree at Aoyama Gakuin University.
Posizioni attive di Hiroki Narita
| Società | Posizione | Inizio |
|---|---|---|
Cardio, Inc. | Direttore/Membro del Consiglio | 15/07/2009 |
Daiwa Corporate Investment Co., Ltd.
 Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment invests in companies located in Japan. The firm focuses on a broad range of sectors and Industries. It provides financing for buyout, early and growth stage capital requirements. | Investitore di Private Equity | 01/04/2022 |
Precedenti posizioni note di Hiroki Narita
| Società | Posizione | Fine |
|---|---|---|
| RAQUALIA PHARMA INC. | Direttore/Membro del Consiglio | 31/10/2011 |
TMRC Co. Ltd.
 TMRC Co. Ltd. BiotechnologyHealth Technology Operates as a pharma company that researches and develops anti-cancer drugs | Direttore/Membro del Consiglio | - |
Daiwa SMBC Capital Co., Ltd.
 Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Corporate Officer/Principal | - |
| RIBOMIC INC. | Direttore/Membro del Consiglio | - |
REGiMMUNE Corp.
 REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Direttore/Membro del Consiglio | - |
Formazione di Hiroki Narita
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
41
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Daiwa SMBC Capital Co., Ltd.
Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Finance |
Aoyama Gakuin University
 Aoyama Gakuin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
REGiMMUNE Corp.
REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Health Technology |
TMRC Co. Ltd.
TMRC Co. Ltd. BiotechnologyHealth Technology Operates as a pharma company that researches and develops anti-cancer drugs | Health Technology |
Ribomic, Inc.
 Ribomic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures aptamer drug | Health Technology |
Cardio, Inc. | |
Daiwa Corporate Investment Co., Ltd.
Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment invests in companies located in Japan. The firm focuses on a broad range of sectors and Industries. It provides financing for buyout, early and growth stage capital requirements. | Finance |
RaQualia Pharma, Inc.
 RaQualia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development of medicines | Health Technology |
